Member Info for Newboy58

And how long you been here bobust, 5 minutes??

This is the rns that drew me in 5 years ago, same much different direction but same old jam tomorrow messaging...

https://www.lse.co.uk/rns/AFC/progress-update-nwhg9lodpwwopt2.html

Sarah Gilbert was just on Andrew Marr, worth watching on catch up if you missed it, very impressive Professor.

Accrington Stanley, who are they??

Usual BS, sells the SP right down so the W2T deal does t look like such a **** deal, then gets lots of PHE shares back to fill up his pot... Capitalism at its finest! Gordon Gekko would be proud..

Have a look at the max chart on google, a joke ..... 13 Years of pump and dump... I wonder how much money they have spent in that time for £0 return?

It was 25p in 2007...

There is more to life than a new Maserati..... Hard to find a decent human being in the middle of AIM

Like his honesty there...

Looks like the W2T deal is about to go through then, I hope these people are up to the task of delivering the PHE on the world and not just another load of easy cash driven chancers. GLA

Yea, I didn't read it properly, my bad!

Ahh,Okey dokey Pitlick.. great deal for W2T.. 10% of PHE for £20k if the deal goes through...

https://techcrunch.com/2020/04/17/university-of-oxford-coronavirus-vaccine-trial-aims-to-have-500-people-in-testing-by-mid-may/

I'm hoping DR is holding out rather than being turned over by W2T . ... How they are worth 40% of PHE is beyond me..

I'm peed off tbh, been waiting ages for news on the next step and all we get is more dilution and the companies biggest cheerleader selling at least 50% of his holding, wtf is going on.

Or not ...

I think AFC sold their 23% holding in W2T for about £20k, wonder who bought those?! All a bit shady, sure MAN will be on soon saying it's all above board and squeeky clean...

Can buy easily at sup 30p??!

Looks like it.

I had a straight choice, L&G or Aviva to invest in, I always pick the wrong ****ing horse.... I should go through all the pros and cons, make a choice then do the opposite....

That's a shame, I thought he believed in the product.

I wonder how many he is due back with the proposed W2T merger!?

Then more dilution... Come on Dave, some news on the direction of the business is well overdue now...

Kinda makes you wonder how it's at -9%.. ?

Or this one!? :) :)

London South East
Share PricesOmega Dia Share PriceOmega Dia Regulatory NewsCOVID-19 Consortium MOU
Pin to quick picksOmega Dia Regulatory News (ODX)
ODX Share Price
ODX Share
Price
ODX Share News
ODX Share
News
ODX Share Chat
ODX Share
Chat
283
ODX Share Trades
ODX Share
Trades
1,229
ODX Live RNS
ODX
Live RNS
ODX Information Buy ODX SharesBuy ODX SharesAdd ODX to WatchlistAdd ODX to WatchlistAdd ODX to AlertAdd ODX to AlertAdd ODX to myTerminalAdd ODX to myTerminal
Share Price Information for Omega Dia (ODX)
London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
28.50
Bid:
28.00
Ask:
29.00
Change:
-2.9

COVID-19 Consortium MOU
Thu, 9th Apr 2020 07:00

RNS Number : 2892J
Omega Diagnostics Group PLC
09 April 2020



OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")



Memorandum of Understanding

COVID-19 Consortium





Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and allergy testing announces that it has signed a Memorandum of Understanding ("MOU") with three other companies from across the UK, in conjunction with the University of Oxford to form the UK Rapid Test Consortium ("UK-RTC") in order to jointly develop and manufacture a COVID-19 Point of Care antibody test as part of the Government's five pillar national testing strategy for COVID-19.



The UK-RTC, which was announced by the UK Government yesterday, comprises Omega, Abingdon Health Limited, BBI Solutions Limited, CIGA Healthcare Limited, and the University of Oxford (the "Parties") and was formed at the request of the UK Government to support the development and manufacturing scale-up of a COVID-19 lateral flow antibody test ("COVID-19 Rapid Test") to determine whether people have developed immunity after contracting the virus.



The MOU is for an initial period of six months and the Parties will collaborate to utilise their combined lateral flow test design and manufacturing expertise to optimise the design for potential accelerated scale-up to manufacturing of the COVID-19 Rapid Test.



Once the COVID-19 Rapid Test reaches design freeze, then the specification and standard operating procedures will be shared with each party of the consortium to enable manufacturing and/or assembly to be undertaken at each site, including at Omega's manufacturing facility in Alva, Scotland, according to capability.



Colin King, CEO of Omega commented: "We are delighted to be part of this consortium and to support the Scottish and UK Governments' efforts to combat the Coronavirus pandemic and look forward to using Omega's manufacturing knowledge and capabilities in supporting and furthering this objective."



The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.